#diagnostics - Techseriesinsight

September 3, 2025
Business Wire
Biotechnology, Healthcare, News

Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease

C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, is proud to announce that its early achievements while based in St. Louis are...

July 29, 2025
PRNewswire
Biotechnology, News

Hope in New Alzheimer’s Blood Test

TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a strategic collaboration with T-NeuroDx, a pioneering diagnostics company dedicated to developing innovative solutions for detecting neurodegenerative diseases,...

July 11, 2025
PRNewswire
Artificial Intelligence, News

BCC Research Presents 2024 Diagnostics Research Review: Market Growth and Innovations

BCC Research announces the release of its “2024 Diagnostics Research Review,” shining a spotlight on the significant growth of and advances in the global diagnostics market. The review provides...

April 9, 2025
PRNewswire
Biotechnology

Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions

Oxford Nanopore Technologies, the company behind a new generation of sequencing-based molecular analysis technologies, and Cepheid, a leading molecular diagnostics company, today announced a strategic collaboration to develop and commercialize...

April 2, 2025
PRNewswire
Healthcare

Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (HPV) screening to help identify women who are...